[{"id":"65ef933e-5bd4-4594-99fd-d1500caca8a8","acronym":"","url":"https://clinicaltrials.gov/study/NCT00068523","created_at":"2021-01-18T00:10:09.988Z","updated_at":"2024-07-02T16:36:42.765Z","phase":"","brief_title":"Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies","source_id_and_acronym":"NCT00068523","lead_sponsor":"Case Comprehensive Cancer Center","biomarkers":" CCND1 • HLA-B","pipe":"","alterations":" ","tags":["CCND1 • HLA-B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • cyclosporine • cyclophosphamide intravenous • methylprednisolone oral • methylprednisolone sodium succinate"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 06/01/2003","start_date":" 06/01/2003","primary_txt":" Primary completion: 03/01/2004","primary_completion_date":" 03/01/2004","study_txt":"","study_completion_date":"","last_update_posted":"2020-07-27"}]